First Capital Realty Announces Completion of Property Dispositions

Real Estate & Development

First Capital Realty Inc. (“First Capital Realty”) (TSX: FCR), one of Canada’s largest owners, developers and managers of grocery anchored, retail-focused urban properties, announced today that it has completed approximately $165 million of previously disclosed property dispositions.

On March 27, 2018, First Capital closed the sale of 18 properties that comprise a portion of the portfolio it owned through its joint venture interest in Main and Main Urban Realty for aggregate gross proceeds of $298 million, or approximately $112 million at First Capital’s interest. First Capital received net proceeds (after repayment of debt) of approximately $99 million, which was satisfied in cash.

On March 21, 2018, First Capital closed the sale of a 50.5% non-managing interest in its necessity-based London, Ontario portfolio, for $66 million ($359 per square foot), which was satisfied in cash. The First Capital London portfolio comprises six grocery and pharmacy anchored properties totalling 368,000 square feet.

Jordan Robins, Executive Vice President and COO said: “We are very pleased with the successful execution of these transactions, which enable First Capital to reduce debt and to recycle capital into our major retail properties and intensification projects within our target nodes in core urban markets. We are also happy to expand our existing partnership with a major institutional investor through their investment in our Londonportfolio.”


First Capital Realty is one of Canada’s largest owners, developers and managers of grocery anchored, retail-focused urban properties where people live and shop for everyday life. The Company currently owns interests in 161 properties, totaling approximately 25 million square feet of gross leasable area.

Forward-looking Statement Advisory

This press release contains forward-looking statements and information within the meaning of applicable securities law, including statements regarding the anticipated impact of dispositions and acquisitions of properties by the Company. These forward-looking statements are not historical facts but, rather, reflect the Company’s current expectations and are subject to risks and uncertainties that could cause the outcome to differ materially from current expectations. Such risks and uncertainties include, among others, general economic conditions; tenant financial difficulties, defaults and bankruptcies; increases in operating costs and property taxes; First Capital Realty’s ability to maintain occupancy and to lease or re-lease space at current or anticipated rents; development, intensification and acquisition activities; residential development, sales and leasing; risks in joint ventures; environmental liability and compliance costs and uninsured losses; the Company’s ability to complete dispositions and the timing, terms and anticipated benefits of any such dispositions; in addition to those risks discussed in the Company’s MD&A for the year ended December 31, 2017 and in its current Annual Information Form. Readers, therefore, should not place undue reliance on any such forward-looking statements. First Capital Realty undertakes no obligation to publicly update any such forward-looking statement or to reflect new information or the occurrence of future events or circumstances except as required by applicable securities law.

All forward-looking statements in this press release are made as of the date hereof and are qualified by these cautionary statements.

The FBAI Wellness city’s first health and wellness event at JW Marriott on 17th March, 2018


This weekend saw the top wellness influencers and enthusiasts of the city congregate at JW Marriott for the first ever one-day event celebrating health and wellbeing, curated by FBAI Wellness. 

Mumbai “Said Yes” to Wellness, as the FBAI foundered by Sameer Malkani & Saloni Malkani, united fitness, nutrition and wellness enthusiasts with the top trainers, nutritionists and wellness influencers to support and encourage proactive wellness.

The event was a huge success with speakers like actress Tanishaa Mukerji talking about her amazing transformation to a healthier self through a conscious eating, well balanced meals, a gruelling fitness regime and buddhism. Celebrity Chef Ranveer Brar who offered his insights into healthy eating. Actress Sameera Reddy had the audience enthralled with her heart felt talk on how she discovered her newer fitter self and her tips for spreading this awareness to the younger generation. Smita Deo, Director Abhinav Deo’s wife spoke insightfully on a panel with influencers like Kalyan Karmarkar on reimagining the modern kitchen. Chef Vicky Ratani and Aditi Dugar, Founder Masque spoke on the importance of local ingredients. 

Other speakers included Shobhaa De’s youngest – Anandita De, Chef Madhuri Ruia, Chef David Cananzi,  Rachna Chachhi, Tripti Gupta, Eefa Shrof and Rushina Ghildiyal 

The highlight of the event was Bijal Doshi’s Bollywood Yoga which was so appreciated by the audience that an encore was requested as well as the Zumba session by Jignya Johri

Another huge talking point was the power brunch and the wellness high tea by the executive chef of JW Marriott. Well thought out to offer a healthy but yet delicious and Lavish spread of delicacies, from a salad station to live barley and quinoa station to healthy mains and even desserts!

The event tackled topics such as dealing with obesity, duration of healthy menus at home, the secret to mind body wellness, tackling body issues, age renewal, kids nutrition and even the fashion of fitness

“Living a life with wellness at its core is the guiding principle of FBAI Wellness which is why we “Say Yes” to Wellness and are proud that many in our Institute network, including JW Marriott and Godrej, are embracing this important campaign,” said Sameer Malkani, Founder FBAI and FBAI Wellness.

“With a shared holistic approach to wellness, we at the JW Marriott Mumbai Juhu along with Food Bloggers Association of India have come together to bring you mind-body balance through a transformative day of in depth discussion on wellness. This initiative of FBAI Wellness by one of India’s leading food blogger association is indeed path breaking and opening more doors to well-being”, says Sharad Puri, General Manager at the JW Marriott Mumbai Juhu

This event makes a start to a healthy future!

EverCompliant Secures Strategic Investment From American Express Ventures to Help Fight Electronic Money Laundering  

Business, Safety, Society, Technology, Telecom & Internet

Investment supports EverCompliantcontinued growth as it defendagainst online merchant fraud

EverCompliant, the pioneer of Electronic Money Laundering Detection and Prevention (also known as Transaction Laundering), announced a strategic investment from American Express Ventures, which joins existing investors Arbor Ventures, Carmel Ventures, StarFarm Ventures and Nyca Partners. EverCompliant will use the funds to ramp up its team and continue to optimize and develop new technology.

Transaction Laundering occurs when a fraudster uses a legitimate online merchant account to funnel illegal transactions through a merchant processor, online marketplace or other merchant service provider. The continued growth of online commerce has created more opportunities for illicit players to use legitimate online storefronts to mask their identities, leading to an increase in Transaction Laundering.

EverCompliant’s automated detection capabilities enable merchant service providers to identify and eliminate unknown and fraudulent merchants. Continual monitoring and verification of third-party identities helps merchant service providers prevent the processing of fraudulent transactions, reducing the risk of chargebacks, financial losses and damage to their reputation. EverCompliant’s research shows that, on average, there are 6%-10% additional unknown and unregistered merchants over the size of a merchant service provider’s known portfolio, who are illegally committing Transaction Laundering. This phenomenon amounts to nearly $500 billion a year worldwide. These transactions may involve illegal goods sold by unregistered merchants, demonstrating that Transaction Laundering fraud is a growing issue for the payments industry.

“We are thrilled that American Express has decided to invest in our company,” said Ron Teicher, CEO of EverCompliant. “Their investment shines a spotlight on a growing problem in the payments industry. Having a strong relationship with this global payments network, paired with our continuous merchant risk management capabilities, will equip the industry with what they need to combat this new form of money laundering.”

“EverCompliant’s technology is helping merchant acquirers, payment aggregators and other service providers prevent bad actors from infiltrating their systems and ensure only legitimate transactions get processed,” said Harshul Sanghi, Managing Partner of American Express Ventures, the strategic investment group of American Express. “As more commerce shifts online, the need for advanced solutions that can help payment service providers fight fraudulent transactions will continue to grow. We look forward to helping EverCompliant as it addresses increased demand for its technology.”

EverCompliant’s customers currently include some of the largest institutions across North AmericaEurope, and Asia, who collectively monitor millions of merchants within their platform. The company’s proprietary and highly-effective method for uncovering Transaction Laundering has fueled a growing demand among merchant service providers and yielded a 300%+ increase in company growth in 2017.

About American Express Ventures

As the strategic investment group within American Express, Amex Ventures seeks to invest in innovative startups in order to enhance our company’s core capabilities and accelerate our efforts in consumer commerce and B2B services. Across the globe, we strive to foster meaningful relationships with startups in our portfolio and beyond. Visit for more information.

About EverCompliant

EverCompliant is the pioneer and industry leader in Electronic Money Laundering Detection and Prevention (also known as Transaction Laundering.) The company’s flagship product, MerchantView™, is the first and only dedicated solution on the market designed from its core to detect and prevent Transaction Laundering. MerchantView applies proprietary, cyber intelligence technology to identify unknown and hidden merchants funneling transactions through seemingly legitimate storefront websites. EverCompliant’s technology has been adopted by large-scale financial institutions and payment service providers in AsiaEurope, U.S. and the Middle East. EverCompliant is headquartered in New York City with offices in San FranciscoShanghai and Tel Aviv.

Vistra Announces Acquisition of Global Expandia in Indonesia


HONG KONGMarch 13, 2018 /PRNewswire/ — Vistra, one of the world’s leading corporate service providers of international incorporations, trust, fiduciary, private office, international expansion and fund administration services, has acquired Global Expandia, a Jakarta based firm providing market entry and other related services to foreign-owned investors operating in Indonesia. This acquisition adds to Vistra’s growing global footprint for International Expansion services by establishing a presence in Indonesia, the largest economy in Southeast Asia, which is an attractive market for local and foreign businesses.

(Logo: )

Established in 2014, Global Expandia has built a reputation as a one stop solution for foreign companies making direct investments into Indonesia, offering a comprehensive service portfolio across company formation, tax compliance, accounting, bookkeeping, payroll and work permits. The team of 17 led by founders Miguel Latorre and Elsye Yaw will join Vistra, with Miguel becoming Managing Director of Vistra’s International Expansion division in Indonesia.

Announcing the acquisition, Vincent Bremmer, Group Managing Director of International Expansion at Vistra, said, “Indonesia has emerged as one of the leading jurisdictions in Asia for international companies to expand into. Globally, it is the fourth most populous nation with a young labour force; representing a key market for Vistra as we strengthen our Southeast Asian business. The acquisition of Global Expandia will not only grow our network, but it will also prove beneficial for our existing businesses in SingaporeHong Kong and Mainland China where we have clients already operating within Indonesia or with plans to do so. Miguel and Elsye have successfully built and grown Global Expandia and their ongoing leadership is important to ensure our Indonesian business continues along the same growth trajectory. Their expertise will be integral to our growth in the region. Our Vistra Singapore team has already built a strong working relationship with Miguel and Elsye, and both now have the opportunity to better serve our clients with a broad and innovative set of services.” Vistra were advised on the transaction by Foulger Underwood.

Miguel Latorre, co-founder of Global Expandia, added, “This acquisition is a fantastic opportunity for all of us at Global Expandia, and is also a reflection of the work our team has done in making our company a major provider in Indonesia for supporting foreign investment. Vistra will provide us with the platform to attract new foreign clients to Indonesia through their extensive global network. This is a breakthrough step for all of us and we are excited to continue growing with Vistra.”

Pittsburgh Penguins, Covestro and Carnegie Mellon’s College of Engineering unite to ‘Rethink the Rink’

Science, Technology

‘Make-a-Thon’ first step in unique collaboration exploring new ways to make hockey safer for players of all ages

PITTSBURGHMarch 12, 2018 /PRNewswire/ — The Pittsburgh Penguins are teaming up with two international giants of science and technology on a bold initiative to make hockey safer at all levels.

“Rethink The Rink,” a first-of-its kind project, will challenge students from Carnegie Mellon University’s College of Engineering to develop material solutions that enhance the safety of the sport without compromising game performance. The first initiative will focus on redesigning the rink dasher boards and glass. As students apply their creativity and academic strength to the challenge, they will have access to experts and materials technologies from Covestro, a high-tech polymers producer and “Official Innovation Partner of the Pittsburgh Penguins.”

“Players are bigger, faster and stronger than ever before, and so our challenge is to find new ways to keep them safer and reduce injuries,” said David Morehouse, president and CEO of the Penguins. “This collaboration with Covestro and Carnegie Mellon is a specific attempt to use recent advances in material science to address the physical boundary that surrounds a hockey rink. Can we come up with a material solution that reduces the impact of players hitting the boards and makes the game safer for players of all ages?”

The first major step in the process will be a “Make-a-thon” March 12-16 at the College of Engineering. The interactive event will bring together teams of CMU students to design and develop prototypes for testing.

If successful, the prototypes will be submitted to experts at the NHL and USA Hockey for their feedback. Testing could then be conducted by amateur players at the FedEx Rink at the UPMC Lemieux Sports Complex in Cranberry.

“I cannot imagine better partners than Covestro and Carnegie Mellon Engineering, acknowledged global engines of innovation in materials and engineering,” Morehouse said. “Combined with insight from the Penguins and the NHL on the hockey and rink management side, we think it is an exceptional team to explore ways to make an inherently physical sport safer for all players. This can be a meaningful research project that, if we achieve our goal, could help make a long-term impact on the game.”

The idea for “Rethink the Rink” began in a series of conversations between Morehouse and Jerry MacCleary, CEO of Covestro LLC, which has North American headquarters in Pittsburgh.

“We were drawn to this project for a number of reasons – not only because it combines our passion for problem-solving with our strong focus on safety, but more importantly, because we believe in its long-term potential,” MacCleary said. “We’re writing the playbook as we go, but that’s how innovation happens – by pushing boundaries. And our push will be that much stronger with this powerful trio behind it.”

“At Carnegie Mellon we challenge our students to take on unusual problems, to be innovative, to be inquisitive and to take full advantage of hands-on learning projects like the ‘Rethink the Rink’ challenge,” said James H. Garrett Jr., dean of the College of Engineering. “This initiative, by three world-class organizations, is emblematic of the advanced level of collaboration we practice to drive breakthrough results.”

If successful with the initiative on the dasher boards and glass, the “Rethink the Rink” group would then explore the role of materials in other areas of hockey, including player equipment and rink construction.

“Bringing three Pittsburgh-based organizations together to think creatively about this challenge is an example of the entrepreneurial spirit and energy of the city and indicative of why it is flourishing today,” added Garrett.

About Covestro LLC:
Covestro LLC is one of the leading producers of high-performance polymers in North America and is part of the global Covestro business, which is among the world’s largest polymer companies with 2016 sales of EUR 11.9 billion. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, construction, wood processing and furniture, electrical and electronics, and medical industries. Other sectors include sports and leisure, cosmetics and the chemical industry itself. Covestro has 30 production sites worldwide and employed approximately 15,600 people at the end of 2016.

New Late-Breaking Study Finds Wearable Electrocardiogram (ECG) Monitoring Patch Can Detect Atrial Fibrillation Earlier and More Efficiently than Routine Care

Health, Science

Janssen leads in cardiovascular innovation using real-world data to detect asymptomatic atrial fibrillation
Home-based clinical study underscores the game-changing role of digital technology in future of health care

ORLANDO, Fla.March 10, 2018  — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced late-breaking results of a new home-based clinical trial showing that a wearable continuous electrocardiogram (ECG) monitoring patch can identify people with asymptomatic atrial fibrillation (AFib) earlier and more efficiently than routine care. One-year findings from the investigator-initiated study, mSToPS (mHealth Screening To Prevent Strokes), done in collaboration with Scripps Translational Science Institute (STSI), Aetna and iRhythm Technologies, Inc., were presented today during a Featured Clinical Research Session at the American College of Cardiology’s 67th Annual Scientific Session (ACC.18).

Approximately six million Americans have AFib, putting them at an increased risk of stroke.i In fact, one in three people with AFib will experience a stroke during his or her lifetimeii, and one in four will experience heart failureiii. Unfortunately, up to 30 percent of all AFib cases go undiagnosed until life-threatening complications occuriv, signaling a critical need for more efficient and scalable screening methods. To address this challenge, researchers initiated the mSToPS study to understand how digital technology can advance large-scale screening programs.

“We hope that a digital infrastructure will help reimagine how clinical trials can be performed and that this study will be a useful template for remote enrollment and participant engagement,” said Eric Topol, MD, Founder and Director, STSI, La Jolla, CA. “We will have follow-up data to determine if earlier detection of AFib translates into long-term clinical benefits, including reduction of stroke and potential cost savings.”

CLICK TO TWEET: Wearable ECG monitoring patch helps detect asymptomatic AFib vs routine care in new late-breaking home-based clinical study #mSToPS #ACC18

In the study, 1,738 patients underwent continuous ECG monitoring using a wearable patch over a four-week period, divided into two two-week intervals. For each participant enrolled, two matched patients were selected, totaling 3,476 patients in the observational control group; these patients received routine care, which included regular visits to a primary care physician to address general health issues. The primary endpoint was the time to first diagnosis of AFib.

At one year, researchers found:

  • AFib was newly diagnosed in 6.3 percent (109) of patients wearing the ECG monitoring patch compared to 2.3 percent (81) in the control group receiving routine care (HR=2.8, p<0.0001)
    • Of the 109 patients diagnosed in the ECG monitoring patch group, 65 were found to have AFib through the ECG patch with the remainder diagnosed in the clinical setting
    • The majority of patients diagnosed with AFib had a relatively low burden of AFib with only 4.3 percent having persistent AFib
    • Besides AFib episodes, 70 patients in the ECG monitoring patch group were found to have potentially actionable arrhythmias1
  • Approximately 5.4 percent of patients wearing the ECG monitoring patch initiated anticoagulant treatment compared to 3.4 percent in the control group (p=0.0004)

“We are honored to team up with STSI, Aetna and iRhythm Technologies on this groundbreaking study,” said JoAnne Foody, MD, FACC, FAHA, Cardiovascular Therapeutic Area Head, Janssen Pharmaceuticals, Inc. “By leading innovative real-world research to help increase the early detection of AFib, we are encouraging more informed patient and physician discussions.”

CLICK TO TWEET: Bringing together digital technology and health care – wearable ECG patches could transform how AFib is screened #mSToPS #ACC18

Four-month results of mSToPS were previously presented at the American Heart Association (AHA) Scientific Sessions 2017.

More about mSToPS
A randomized, controlled trial involving Aetna health insurance members from across the United States, mSToPS explores the use of an all-digital (recruitment, monitoring and follow-up) program to enable screening with an ECG monitoring patch for undiagnosed AFib in the home setting compared to routine medical care. Inclusion criteria were developed to include a broad population of patients thought to be more likely to have undiagnosed AFib, including those aged 75 years or older, males over the age 55, or females over 65 years with one or more co-morbidities.

Of the 102,553 individuals who met the eligibility criteria and were invited to participate, 1,738 patients were enrolled and monitored in the group assigned the ECG monitoring patch. For the routine care, observational group, two matched controls were selected for each ECG monitored participant from the pool of individuals who were originally eligible for the study; matching was based on sex, age and CHA2DS2-VASc score. Mean age was 73.7 with 40.5 percent being female.

Patients in the ECG monitoring patch group used the iRhythm ZIO® XT Patch wearable sensor, an FDA-cleared, single-use, 14-day, ambulatory ECG monitoring adhesive patch that monitors and retains in memory the wearer’s continuous ECG for up to two weeks. All participants were asked to wear two different self-applied patches, for a maximum of two weeks for each patch, approximately three months apart. A total of 481 individuals wore one patch, and 1,257 wore both ECG monitoring patches, providing a median total monitoring time of 593.3 hours per monitored participant.

About AFib
AFib is a type of irregular heartbeat, sometimes caused by a heart valve problem, that can lead to the formation of blood clots in the heart. These clots can travel to the brain and cause a stroke. It is the most common sustained arrhythmia. AFib increases the risk of stroke by five-fold, and accounts for almost one-third of all strokes.v,vi,vii For those individuals who experience a stroke due to AFib, 20 percent were not aware they had AFib until the time of their stroke or shortly thereafter.viii When AFib is diagnosed, anticoagulant treatment can decrease the risk of stroke by more than 65 percent.ix

Puerto Rico Launches Largest Public Health Campaign Since Hurricane Maria

Society, World

One-day campaign aims to immunize a record-setting 25,000 people at more than 50 locations across island

SAN JUAN, Puerto RicoMarch 10, 2018 /PRNewswire-USNewswire/ — One of the world’s largest-ever one-day vaccination campaigns happens Saturday, March 10, across Puerto Rico. Up to 25,000 people will be vaccinated against influenza in a daylong event conducted by the VOCES Puerto Rico Vaccination Coalition, Puerto Rico’s Department of Health, The CDC Foundation, Direct Relief and others.

“A year-round flu season, combined with the damage inflicted by Hurricane Maria to Puerto Rico’s vaccine inventories, has left the island’s population severely vulnerable to influenza and other conditions,” said Lilliam Rodríguez, President and Founder of VOCES Puerto Rico. “Immediate action through immunization is needed to protect the lives and health of the population. Today’s island-wide vaccination campaign aims to close the immunization gap and promote health for all.”

Puerto Rico’s healthcare system was devastated by Hurricane Maria last September, leaving fewer Puerto Ricans vaccinated this flu season. Dozens of clinics were shut and most lost the electrical power needed to refrigerate vaccines. Many clinics still don’t have electrical grid power.

Free influenza vaccinations will be offered Saturday at the 18,500-person capacity Jose Miguel Agrelot Coliseum in San Juan and more than 50 vaccination centers, pharmacies, hospitals and primary health centers throughout the island.

The humanitarian aid group Direct Relief provided 40,000 doses of influenza vaccine donated by pharmaceutical maker Sanofi S.A. for the initiative. Direct Relief is also providing logistics support and funding to rent the Coliseum and hire support staff for the event.

“Sanofi Cares North America is proud to partner with Direct Relief in supporting this unprecedented flu vaccination campaign for the residents of Puerto Rico,” said Peter Lalli, President of Sanofi Cares North America. “We stand with the people of Puerto Rico as the recovery from the devastation of Hurricane Maria continues.”

Flu has been widespread in Puerto Rico this season. The Centers for Disease Control and Prevention on Friday reported that “34 states plus Puerto Rico continue to report widespread flu activity,” and while activity dropped from this year’s peak, it still matches the height of the 2015-16 season.

“We remain committed to making vaccines accessible to the Puerto Rican community, and to reach any region of the Island that needs it,” said Dr. Rafael Rodríguez Mercado, Secretary of Health, in a Spanish-language statement issued by VOCES.

In the six months since Hurricane Maria made landfall, Direct Relief has supported 58 health facilities across Puerto Rico with $61.9 million in medications and medical supplies.

“Hurricane Maria dealt a doubly cruel blow to Puerto Rico, devastating countless lives and livelihoods while damaging the health facilities, systems, and infrastructure needed to recover,” said Thomas Tighe, president and CEO, Direct Relief. “That’s why the work of VOCES and others to promote health and wellbeing across Puerto Rico are so critical. It’s a privilege for Direct Relief to support today’s mass immunization campaign and participate in these exceptional efforts to help people in Puerto Rico recover and live healthy lives.”

About Direct Relief

A humanitarian organization committed to improving the health and lives of people affected by poverty or emergencies, Direct Relief delivers lifesaving medical resources throughout the world to communities in need—without regard to politics, religion, or ability to pay. With operations spanning more than 70 countries and all 50 U.S. states, Direct Relief is the only charitable nonprofit to obtain Verified Accredited Wholesale Distributor (VAWD) accreditation by the National Association of Boards of Pharmacy. Among other distinctions, Direct Relief earns a perfect score of 100 from independent evaluator Charity Navigator, was listed among the world’s most innovative nonprofits by Fast Company, and has received the CECP Directors’ Award, the Drucker Prize for Nonprofit Innovation, and the President’s Award from Esri for excellence in GIS mapping. For more information, please visit